Home > PE Ratio > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ONESOURCE SPECIALTY PHARMA is -50.40.

Share Price ₹1,587.4Apr 02,2025
Market Cap ₹18,159.3 Cr
Earnings-TTM₹-360.3 CrTTM-Standalone Results
Price/Earnings-50.40xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ONESOURCE SPECIALTY PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ONESOURCE SPECIALTY PHARMA is calculated as :

Current Market Cap [ ₹18,159.3 Cr] as on Apr 02,2025

(/) Earnings [ ₹-360.3 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ -50.40x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay -50.40 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ONESOURCE SPECIALTY PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of ONESOURCE SPECIALTY PHARMA


PE Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA

- ONESOURCE SPECIALTY PHARMA 's latest p/e ratio is -50.40x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending to Apr 02,2025 averaged nanx.

- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of x from fiscal years ending March 2018 to 2022.

- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in at x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in of x.


How does ONESOURCE SPECIALTY PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ONESOURCE SPECIALTY PHARMA -360.33-50.4018,159.3
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0035.81411,306.0
DIVIS LABORATORIES LTD2,067.0072.73150,343.0
CIPLA LTD5,000.4323.46117,323.0
TORRENT PHARMACEUTICALS LTD1,862.0058.33108,619.0
DR REDDYS LABORATORIES LTD5,428.6017.6795,941.5
MANKIND PHARMA LTD2,050.7348.7199,891.5
ZYDUS LIFESCIENCES LTD4,591.8019.5389,680.6
LUPIN LTD2,892.1031.7291,742.2
AUROBINDO PHARMA LTD3,500.2519.2367,294.6
ABBOTT INDIA LTD1,334.4647.0962,839.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ONESOURCE SPECIALTY PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -50.40x
Max industry PE 72.73x
Median industry PE 31.72x
Average industry PE 29.44x



You may also like the below Video Courses